Gabapentin and Eye allergy - a phase IV clinical study of FDA data

Summary:

Eye allergy is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 50-59 old, also take Pantoprazole, and have High blood pressure.

The phase IV clinical study analyzes which people have Eye allergy when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.

What is Eye allergy?

Eye allergy is found to be associated with 206 drugs and 284 conditions by eHealthMe. Check the latest studies of Eye allergy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 17 people (0.01%) have Eye allergy.

Among these 17 people:

What is the gender of people who have Eye allergy when taking Gabapentin? *

female: 100 %
male: 0.0 %

What is the age of people who have Eye allergy when taking Gabapentin? *

What are other drugs people take besides Gabapentin? *

What are other side effects people have besides Eye allergy? *

Headache (pain in head): 12 people, 70.59%
Drug Ineffective: 11 people, 64.71%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 58.82%
Oropharyngeal Pain: 10 people, 58.82%
Cough: 10 people, 58.82%
Fatigue (feeling of tiredness): 10 people, 58.82%
Ligament Sprain (ligament stretched): 10 people, 58.82%
Joint Pain: 10 people, 58.82%
Eye Pain: 10 people, 58.82%
Indigestion: 9 people, 52.94%

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 52.94%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 47.06%
Urinary Tract Infection: 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Sleep Disorder: 1 person, 5.88%
Sinusitis (inflammation of sinus): 1 person, 5.88%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 5.88%
Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
Nervousness: 1 person, 5.88%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Eye allergy?

- Check whether Eye allergy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,990 reports)

Eye allergy treatments and more:

Eye allergy (3,635 reports)

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye allergy:

Eye allergy (206 drugs)

Browse all the conditions that are associated with Eye allergy:

Eye allergy (284 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.